Park Ha Biological Technology Co., Ltd. (PHH)
NASDAQ: PHH · Real-Time Price · USD
5.89
+0.20 (3.51%)
At close: Jan 21, 2025, 4:00 PM
5.96
+0.07 (1.19%)
After-hours: Jan 21, 2025, 4:00 PM EST

Company Description

Park Ha Biological Technology Co., Ltd., an investment holding company, provides personalized skincare products in the People’s Republic of China.

The company operates in two segments, Product Sales and Franchise Service. It offers private label skincare products, such as basic skin physical protection, exfoliation, sebum film repairing, surface microecological balance, and anti-aging products under the Park Ha brand, as well as customized skincare services.

The company also provides products through a franchise model. It serves franchisees and retail customers in the skincare industry.

The company was incorporated in 2022 and is headquartered in Wuxi, the People’s Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.

Park Ha Biological Technology Co., Ltd.
Country China
Founded 2016
IPO Date Dec 27, 2024
Industry Household & Personal Products
Sector Consumer Staples
Employees 25
CEO Xiaoqiu Zhang

Contact Details

Address:
901 & 901-2, Building C
Wuxi, 214000
China
Phone 86 40 0012 7562
Website parkha.cn

Stock Details

Ticker Symbol PHH
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
IPO Price $4.00
CIK Code 0001986247
CUSIP Number 693320103
ISIN Number US6933202029
SIC Code 2840

Key Executives

Name Position
Xiaoqiu Zhang Chief Executive Officer, Chairperson of the Board of Directors
Li Wang Director
Xiaoyan Zhu Chief Financial Officer
Xinyu Li Product Manager, Chief Technology Officer

Latest SEC Filings

Date Type Title
Jan 7, 2025 6-K Report of foreign issuer
Dec 30, 2024 6-K Report of foreign issuer
Dec 27, 2024 424B4 Prospectus
Dec 26, 2024 CERT Certification by an exchange approving securities for listing
Dec 26, 2024 8-A12B Registration of securities
Dec 20, 2024 EFFECT Notice of Effectiveness
Dec 20, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Dec 6, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers
Dec 3, 2024 FWP Free Writing Prospectus
Nov 6, 2024 F-1/A [Amend] Registration statement for certain foreign private issuers